Hepatic encephalopathy therapy: An overview.

about

One-Year Mortality after Traumatic Brain Injury in Liver Cirrhosis Patients--A Ten-Year Population-Based Study.Rifaximin therapy and hepatic encephalopathy: Pros and cons.

P2860

Q36195323-CE190718-C79E-4D8F-9A22-2B997C796C0C Q42324150-7831DA68-627D-4F4E-9887-A50C2E96702D

P2860

Hepatic encephalopathy therapy: An overview.

Item

http://www.wikidata.org/entity/Q42730495

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Hepatic encephalopathy therapy: An overview.

@en

Hepatic encephalopathy therapy: An overview.

@nl

type

Item

label

Hepatic encephalopathy therapy: An overview.

@en

Hepatic encephalopathy therapy: An overview.

@nl

prefLabel

Hepatic encephalopathy therapy: An overview.

@en

Hepatic encephalopathy therapy: An overview.

@nl

P1476

Hepatic encephalopathy therapy: An overview.

@en

P2093

Chiara Pasquale

http://www.w3.org/2001/XMLSchema#string

Lorenzo Ridola

http://www.w3.org/2001/XMLSchema#string

Oliviero Riggio

http://www.w3.org/2001/XMLSchema#string

P2860

Branched-chain amino acids for hepatic encephalopathy

Rifaximin treatment in hepatic encephalopathy

Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial

Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis.

Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.

Review: surgical shunts and encephalopathy.

P304

54-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4292/WJGPT.V1.I2.54

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51131611

http://www.w3.org/2001/XMLSchema#string

P698

21577297

http://www.w3.org/2001/XMLSchema#string

P932

3091148

http://www.w3.org/2001/XMLSchema#string

Hepatic encephalopathy therapy: An overview.

about

P2860

P2860

Hepatic encephalopathy therapy: An overview.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932